These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23163799)

  • 1. Gene therapy for noninfectious uveitis.
    Chu CJ; Barker SE; Dick AD; Ali RR
    Ocul Immunol Inflamm; 2012 Dec; 20(6):394-405. PubMed ID: 23163799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis.
    Touchard E; Bloquel C; Bigey P; Kowalczuk L; Jonet L; Thillaye-Goldenberg B; Naud MC; Scherman D; de Kozak Y; Benezra D; Behar-Cohen F
    Gene Ther; 2009 Jul; 16(7):862-73. PubMed ID: 19440225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product.
    Touchard E; Benard R; Bigot K; Laffitte JD; Buggage R; Bordet T; Behar-Cohen F
    J Control Release; 2018 Sep; 285():244-251. PubMed ID: 30009894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-TNF-α in the treatment of non-infectious uveitis].
    Hoogewoud F; Kowalczuk L; Bousquet E; Brézin A; Touchard E; Buggage R; Bordet T; Behar-Cohen F
    Med Sci (Paris); 2020 Oct; 36(10):893-899. PubMed ID: 33026332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
    Lee DJ; Biros DJ; Taylor AW
    Int Immunopharmacol; 2009 Aug; 9(9):1079-86. PubMed ID: 19426838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
    Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV
    Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
    Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in gene therapy of uveitis].
    Tao XY; Yang PZ; Lei B
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):281-4. PubMed ID: 23866711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T Cell Therapy for Uveitis: A New Promising Challenge.
    Foussat A; Gregoire S; Clerget-Chossat N; Terrada C; Asnagli H; Lemoine FM; Klatzmann D; LeHoang P; Forte M; Bodaghi B
    J Ocul Pharmacol Ther; 2017 May; 33(4):278-284. PubMed ID: 28448237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular sarcoidosis].
    Springer-Wanner C; Brauns T
    Z Rheumatol; 2017 Jun; 76(5):391-397. PubMed ID: 28516270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of biologics for the treatment of noninfectious uveitis.
    Takeuchi M
    Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
    Thomas AS
    Curr Opin Ophthalmol; 2019 May; 30(3):138-150. PubMed ID: 30844945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials.
    Thng ZX; Bromeo AJ; Mohammadi SS; Khatri A; Tran ANT; Akhavanrezayat A; T T Than N; Nguyen KS; Yoo WS; Mobasserian A; Or CCM; Nguyen QD
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):297-309. PubMed ID: 38129984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologics in the treatment of uveitis.
    Imrie FR; Dick AD
    Curr Opin Ophthalmol; 2007 Nov; 18(6):481-6. PubMed ID: 18163000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis.
    Whitcup SM; Robinson MR
    Ann N Y Acad Sci; 2015 Nov; 1358():1-12. PubMed ID: 26200808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
    Dick AD; Tundia N; Sorg R; Zhao C; Chao J; Joshi A; Skup M
    Ophthalmology; 2016 Mar; 123(3):655-62. PubMed ID: 26712559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.
    Nussenblatt RB; Thompson DJ; Li Z; Chan CC; Peterson JS; Robinson RR; Shames RS; Nagarajan S; Tang MT; Mailman M; Velez G; Roy C; Levy-Clarke GA; Suhler EB; Djalilian A; Sen HN; Al-Khatib S; Ursea R; Srivastava S; Bamji A; Mellow S; Sran P; Waldmann TA; Buggage RR
    J Autoimmun; 2003 Nov; 21(3):283-93. PubMed ID: 14599854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pediatric patients with noninfectious idiopathic uveitis and noninfectious uveitis associated with an underlying systemic disease: from a referral center in Turkey.
    Ozdel S; Baglan E; Gungor T; Yazılıtas F; Cakıcı EK; Ozdal PC; Bulbul M
    Postgrad Med; 2021 May; 133(4):444-448. PubMed ID: 33691583
    [No Abstract]   [Full Text] [Related]  

  • 20. Dexamethasone for ocular inflammation.
    Saraiya NV; Goldstein DA
    Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.